Halogen Bonds in Ligand-Protein Systems : Molecular Orbital Theory for Drug Design
Halogen bonds are highly important in medicinal chemistry as halogenation of drugs, generally, improves both selectivity and efficacy toward protein active sites. However, accurate modeling of halogen bond interactions remains a challenge, since a thorough theoretical investigation of the bonding mechanism, focusing on the realistic complexity of drug-receptor systems, is lacking. Our systematic quantum-chemical study on ligand/peptide-like systems reveals that halogen bonding is driven by the same bonding interactions as hydrogen bonding. Besides the electrostatic and the dispersion interactions, our bonding analyses, based on quantitative Kohn-Sham molecular orbital theory together with energy decomposition analysis, reveal that donor-acceptor interactions and steric repulsion between the occupied orbitals of the halogenated ligand and the protein need to be considered more carefully within the drug design process.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
---|---|
Enthalten in: |
Journal of chemical information and modeling - 60(2020), 3 vom: 23. März, Seite 1317-1328 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Margiotta, Enrico [VerfasserIn] |
---|
Links: |
---|
Themen: |
Halogens |
---|
Anmerkungen: |
Date Completed 17.06.2021 Date Revised 17.06.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1021/acs.jcim.9b00946 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM30599669X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM30599669X | ||
003 | DE-627 | ||
005 | 20231225122403.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/acs.jcim.9b00946 |2 doi | |
028 | 5 | 2 | |a pubmed24n1019.xml |
035 | |a (DE-627)NLM30599669X | ||
035 | |a (NLM)32003997 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Margiotta, Enrico |e verfasserin |4 aut | |
245 | 1 | 0 | |a Halogen Bonds in Ligand-Protein Systems |b Molecular Orbital Theory for Drug Design |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.06.2021 | ||
500 | |a Date Revised 17.06.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Halogen bonds are highly important in medicinal chemistry as halogenation of drugs, generally, improves both selectivity and efficacy toward protein active sites. However, accurate modeling of halogen bond interactions remains a challenge, since a thorough theoretical investigation of the bonding mechanism, focusing on the realistic complexity of drug-receptor systems, is lacking. Our systematic quantum-chemical study on ligand/peptide-like systems reveals that halogen bonding is driven by the same bonding interactions as hydrogen bonding. Besides the electrostatic and the dispersion interactions, our bonding analyses, based on quantitative Kohn-Sham molecular orbital theory together with energy decomposition analysis, reveal that donor-acceptor interactions and steric repulsion between the occupied orbitals of the halogenated ligand and the protein need to be considered more carefully within the drug design process | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Halogens |2 NLM | |
650 | 7 | |a Ligands |2 NLM | |
650 | 7 | |a Proteins |2 NLM | |
700 | 1 | |a van der Lubbe, Stephanie C C |e verfasserin |4 aut | |
700 | 1 | |a de Azevedo Santos, Lucas |e verfasserin |4 aut | |
700 | 1 | |a Paragi, Gabor |e verfasserin |4 aut | |
700 | 1 | |a Moro, Stefano |e verfasserin |4 aut | |
700 | 1 | |a Bickelhaupt, F Matthias |e verfasserin |4 aut | |
700 | 1 | |a Fonseca Guerra, Célia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of chemical information and modeling |d 2005 |g 60(2020), 3 vom: 23. März, Seite 1317-1328 |w (DE-627)NLM153268735 |x 1549-960X |7 nnns |
773 | 1 | 8 | |g volume:60 |g year:2020 |g number:3 |g day:23 |g month:03 |g pages:1317-1328 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.jcim.9b00946 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 60 |j 2020 |e 3 |b 23 |c 03 |h 1317-1328 |